The term Personalised Medicine has been extensively used within the last years to describe a paradigm shift in research and medical application towards an evidence based medicine.
The Tübingen congress will focus on the clinical applicability of PM. Specifically we will highlight aquisition and analysis of highly complex data from patients, the role of functional imaging in multiomics approaches and the translation of these techniques into clinical descision making. Topics of the meeting will encompass different medical fields including oncology, cardiology, immunology, neurological disorders, infectious diseases and others.
